US 11833221
Oligomeric compounds for reducing DMPK expression
granted A61KA61K47/549A61K47/6807
Quick answer
US patent 11833221 (Oligomeric compounds for reducing DMPK expression) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K47/549, A61K47/6807, A61K47/6849